Huons Global, a Korean pharma, expects approval to begin production of its China manufacturing facility very soon, making good on the company’s plan to become a global pharma. China is important to Huons, the company said, already contributing 30% of its ex-South Korea revenues. The plant opening will help Huons expand in China. Huons is developing six innovative drug products, which it hopes to make available globally.
